| Date Filed | Type | Description |
| 06/06/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 03/06/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,870 options to buy
@ $65.32, valued at
$187.5k
|
|
| 01/04/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Exercised 17,501 options to buy
@ $1.3, valued at
$22.8k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 409 shares
@ $35.07, valued at
$14.3k
Bought 1,021 shares
@ $35.1, valued at
$35.8k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Gifted 397,998 shares
@ $0
Gifted 397,998 shares
@ $0 |
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $77.38, valued at
$1M
|
|
| 03/19/2020 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 3,308 options to buy
@ $45.14, valued at
$149.3k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $22.03, valued at
$286.4k
|
|
| 05/15/2019 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 4,650 shares
@ $21.44, valued at
$99.7k
|
|
| 03/21/2019 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 25,652 options to buy
@ $12.95, valued at
$332.2k
|
|
| 03/21/2019 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 5,100 shares
@ $12.18, valued at
$62.1k
|
|
| 06/05/2018 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $3.45, valued at
$44.9k
|
|
| 04/05/2018 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 27,297 options to buy
@ $2.85, valued at
$77.8k
|
|
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2016 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,193 options to buy
@ $8.02, valued at
$41.6k
|
|